Chemed
358 hedge funds and large institutions have $3.99B invested in Chemed in 2018 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 111 increasing their positions, 138 reducing their positions, and 38 closing their positions.
508% more call options, than puts
Call options by funds: $5.98M | Put options by funds: $984K
75% more funds holding in top 10
Funds holding in top 10: 4 → 7 (+3)
2% more funds holding
Funds holding: 352 → 358 (+6)
0.39% less ownership
Funds ownership: 88.3% → 87.91% (-0.39%)
10% less capital inflows, than outflows
Capital inflows: $277M | Capital outflows: $308M
11% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 38
20% less repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 138
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$21.8M |
| 2 |
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$13.8M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$13M |
| 4 |
Waddell & Reed Financial
Overland Park,
Kansas
|
+$12.4M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$11.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$24.6M |
| 2 |
Millennium Management
New York
|
-$18.4M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.6M |
| 4 |
D.E. Shaw & Co
New York
|
-$13M |
| 5 |
CIBC World Markets
New York
|
-$12.7M |
CHE Hedge Fund Activity: Q4 2018 in Review
358 of the 4,504 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q4 2018, worth a combined $3.99B — down 12% from $4.55B a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of CHE and 34 opened new positions — a net loss of 4 holders — while 138 trimmed existing stakes and 111 added.
The largest buyer was Invesco, adding an estimated $21.8M. The largest seller was Goldman Sachs, cutting an estimated $24.6M.
- 358 institutional investors held Chemed (CHE) as of Q4 2018, up from 352 in Q3 2018.
- Funds reported $3.99B of Chemed stock for Q4 2018, down 12% quarter-over-quarter.
- 34 funds opened new Chemed positions in Q4 2018 and 38 closed out, a net change of -4 holders.
- The largest Chemed buyer in Q4 2018 was Invesco, an estimated $21.8M added.
- The largest Chemed seller in Q4 2018 was Goldman Sachs, an estimated $24.6M sold.
Based on aggregated 13F filings for Q4 2018.